Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SpringWorks Therapeutics ...

    NASDAQ: SWTX · Real-Time Price · USD
    46.78
    -0.02 (-0.04%)
    At close: Jun 06, 2025, 10:12 AM

    SpringWorks Therapeutics Statistics

    Share Statistics

    SpringWorks Therapeutics has 75.35M shares outstanding. The number of shares has increased by 1.15% in one year.

    Shares Outstanding

    n/a
    		 75.35M

    Shares Change (YoY)

    n/a
    		 1.15%

    Shares Change (QoQ)

    n/a
    		 0.74%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 327

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 5.96M, so 7.91% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.96M

    Short % of Shares Out

    n/a
    		 7.91%

    Short % of Float

    n/a
    		 9.5%

    Short Ratio (days to cover)

    n/a
    		 1.09

    Valuation Ratios

    The PE ratio is -10.38 and the forward PE ratio is -56.33. SpringWorks Therapeutics's PEG ratio is 0.32.

    PE Ratio

    n/a
    		 -10.38

    Forward PE

    n/a
    		 -56.33

    PS Ratio

    n/a
    		 13.98

    Forward PS

    n/a
    		 3.4

    PB Ratio

    n/a
    		 5.57

    P/FCF Ratio

    n/a
    		 -14.88

    PEG Ratio

    n/a
    		 0.32
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for SpringWorks Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 3.81

    Quick Ratio

    n/a
    		 3.7

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $520,622.28

    Profits Per Employee

    n/a
    		 $-701,442.93

    Employee Count

    n/a
    		 368

    Asset Turnover

    n/a
    		 0.33

    Inventory Turnover

    n/a
    		 1.23

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 17.85% in the last 52 weeks. The beta is 0.7, so SpringWorks Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.7

    52-Week Price Change

    n/a
    		 17.85%

    50-Day Moving Average

    n/a
    		 43.88

    200-Day Moving Average

    n/a
    		 40.66

    Relative Strength Index (RSI)

    n/a
    		 61.86

    Average Volume (20 Days)

    n/a
    		 4,956,012

    Income Statement

    In the last 12 months, SpringWorks Therapeutics had revenue of 191.59M and earned -258.13M in profits. Earnings per share was -3.48.

    Revenue

    n/a
    		 191.59M

    Gross Profit

    n/a
    		 179.04M

    Operating Income

    n/a
    		 -278.13M

    Net Income

    n/a
    		 -258.13M

    EBITDA

    n/a
    		 -278.13M

    EBIT

    n/a
    		 -278.13M

    Earnings Per Share (EPS)

    n/a
    		 -3.48
    Full Income Statement

    Balance Sheet

    The company has 69.75M in cash and 7.91M in debt, giving a net cash position of 61.84M.

    Cash & Cash Equivalents

    n/a
    		 69.75M

    Total Debt

    n/a
    		 7.91M

    Net Cash

    n/a
    		 61.84M

    Retained Earnings

    n/a
    		 -1.15B

    Total Assets

    n/a
    		 505.36M

    Working Capital

    n/a
    		 274.05M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -175.6M and capital expenditures -4.45M, giving a free cash flow of -180.05M.

    Operating Cash Flow

    n/a
    		 -175.6M

    Capital Expenditures

    n/a
    		 -4.45M

    Free Cash Flow

    n/a
    		 -180.05M

    FCF Per Share

    n/a
    		 -2.43
    Full Cash Flow Statement

    Margins

    Gross margin is 93.45%, with operating and profit margins of -145.17% and -134.73%.

    Gross Margin

    n/a
    		 93.45%

    Operating Margin

    n/a
    		 -145.17%

    Pretax Margin

    n/a
    		 -134.73%

    Profit Margin

    n/a
    		 -134.73%

    EBITDA Margin

    n/a
    		 -145.17%

    EBIT Margin

    n/a
    		 -145.17%

    FCF Margin

    n/a
    		 -93.98%

    Dividends & Yields

    SWTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SWTX is $47, which is 0.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $47

    Price Target Difference

    n/a
    		 0.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 19.92

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist